Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib
Chan Y Cheah, Kate Burbury, Jane F Apperley, Francoise Huguet, Vincenzo Pitini, Martine Gardembas, David M Ross, Donna Forrest, Philippe Genet, Philippe Rousselot, Nigel Patton, Graeme Smith, Cynthia E Dunbar, Sawa Ito, Ricardo CT Aguiar, Olatoyosi Odenike, Alla Gimelfarb, Nicholas CP Cross, John F Seymour
Blood | AMER SOC HEMATOLOGY | Published : 2014
Awarded by Victorian Cancer Agency
Awarded by National Institute for Health Research
The authors thank Dr N. Carvalho and Dr E. Velloso (Sao Paulo, Brazil) for clinical updates and Professor Francois Xavier Mahon for providing molecular analysis for French patients. This work was funded in part by the Victorian Cancer Agency (grant CTCB11_18) and the Haematology Society of Australia and New Zealand (New Investigator Scholarship).